Literature DB >> 25215613

IBD candidate genes and intestinal barrier regulation.

Declan F McCole1.   

Abstract

Technological advances in the large scale analysis of human genetics have generated profound insights into possible genetic contributions to chronic diseases including the inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis. To date, 163 distinct genetic risk loci have been associated with either Crohn's disease or ulcerative colitis, with a substantial degree of genetic overlap between these 2 conditions. Although many risk variants show a reproducible correlation with disease, individual gene associations only affect a subset of patients, and the functional contribution(s) of these risk variants to the onset of IBD is largely undetermined. Although studies in twins have demonstrated that the development of IBD is not mediated solely by genetic risk, it is nevertheless important to elucidate the functional consequences of risk variants for gene function in relevant cell types known to regulate key physiological processes that are compromised in IBD. This article will discuss IBD candidate genes that are known to be, or are suspected of being, involved in regulating the intestinal epithelial barrier and several of the physiological processes presided over by this dynamic and versatile layer of cells. This will include assembly and regulation of tight junctions, cell adhesion and polarity, mucus and glycoprotein regulation, bacterial sensing, membrane transport, epithelial differentiation, and restitution.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25215613      PMCID: PMC4357271          DOI: 10.1097/MIB.0000000000000090

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  298 in total

1.  Immune exclusion is a function of IgA.

Authors:  C R Stokes; J F Soothill; M W Turner
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

2.  Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis.

Authors:  Matti Waterman; Wei Xu; Joanne M Stempak; Raquel Milgrom; Charles N Bernstein; Anne M Griffiths; Gordon R Greenberg; A Hillary Steinhart; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2010-12-10       Impact factor: 5.325

Review 3.  Biology of claudins.

Authors:  Susanne Angelow; Robert Ahlstrom; Alan S L Yu
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

4.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 5.  Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut.

Authors:  N J Mantis; N Rol; B Corthésy
Journal:  Mucosal Immunol       Date:  2011-10-05       Impact factor: 7.313

6.  Implication of intestinal VDR deficiency in inflammatory bowel disease.

Authors:  Jung-Hwan Kim; Satoshi Yamaori; Tomotaka Tanabe; Caroline H Johnson; Kristopher W Krausz; Shigeaki Kato; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2012-10-02

7.  The association of MYO9B gene in Italian patients with inflammatory bowel diseases.

Authors:  A Latiano; O Palmieri; M R Valvano; R D'Incà; R Caprilli; S Cucchiara; G C Sturniolo; F Bossa; A Andriulli; V Annese
Journal:  Aliment Pharmacol Ther       Date:  2007-10-15       Impact factor: 8.171

8.  Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4.

Authors:  Carlos A Flores; James E Melvin; Carlos D Figueroa; Francisco V Sepúlveda
Journal:  J Physiol       Date:  2007-06-21       Impact factor: 5.182

9.  Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.

Authors:  Fereshteh Parviz; Christine Matullo; Wendy D Garrison; Laura Savatski; John W Adamson; Gang Ning; Klaus H Kaestner; Jennifer M Rossi; Kenneth S Zaret; Stephen A Duncan
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

10.  Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice.

Authors:  Mathieu Darsigny; Jean-Philippe Babeu; Andrée-Anne Dupuis; Emma E Furth; Ernest G Seidman; Emile Lévy; Elena F Verdu; Fernand-Pierre Gendron; François Boudreau
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more
  47 in total

Review 1.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

2.  T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.

Authors:  Moorthy Krishnan; Declan F McCole
Journal:  Ann N Y Acad Sci       Date:  2017-08-14       Impact factor: 5.691

Review 3.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 4.  Importance of intestinal microenvironment in development of arthritis. A systematic review.

Authors:  Anna Bazsó; Péter Szodoray; Gábor Sütő; Yehuda Shoenfeld; Gyula Poór; Emese Kiss
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

5.  Neutrophils Promote Amphiregulin Production in Intestinal Epithelial Cells through TGF-β and Contribute to Intestinal Homeostasis.

Authors:  Feidi Chen; Wenjing Yang; Xiangsheng Huang; Anthony T Cao; Anthony J Bilotta; Yi Xiao; Mingming Sun; Liang Chen; Chunyan Ma; Xiuping Liu; Chang-Gong Liu; Suxia Yao; Sara M Dann; Zhanju Liu; Yingzi Cong
Journal:  J Immunol       Date:  2018-08-31       Impact factor: 5.422

6.  Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.

Authors:  Yong-Guo Zhang; Rong Lu; Yinglin Xia; David Zhou; Elaine Petrof; Erika C Claud; Jun Sun
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

7.  A Novel ECM1 Splice Site Mutation in Lipoid Proteinosis: Case Report plus Review of the Literature.

Authors:  Linda K Rey; Jürgen Kohlhase; Katrin Möllenhoff; Gabriele Dekomien; Jörg T Epplen; Sabine Hoffjan
Journal:  Mol Syndromol       Date:  2016-03-15

8.  VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.

Authors:  Moorthy Krishnan; Harrison M Penrose; Nilay N Shah; Ronald R Marchelletta; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

9.  The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.

Authors:  Anica Sayoc-Becerra; Moorthy Krishnan; Shujun Fan; Jossue Jimenez; Rebecca Hernandez; Kyle Gibson; Reyna Preciado; Grant Butt; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2020-02-11       Impact factor: 5.325

Review 10.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.